Hannes Holste is a director-level investor and data scientist who has spent 11 years financing and building technology-driven life science companies across the US, Europe, and Asia. At Thiel Capital he blends deep technical fluency in biomedicine and machine learning with strategic investing, supporting portfolio leaders from computational peptide therapeutics to FDA‑breakthrough brain‑computer interfaces. He sits on boards of clinical and AI-first biotech firms (Peptilogics, Ataraxis AI, Blackrock Neurotech) and has operational roots as a biomedical informatics scientist and software engineer, which helps him translate research breakthroughs into scalable products. Fluent in Mandarin and experienced across cross-border markets, he uniquely navigates diverse regulatory and commercialization landscapes. Known for pairing hands‑on data science with venture judgment, he focuses on projects that accelerate discovery through novel algorithms and purpose‑built compute.
11 years of coding experience
5 years of employment as a software developer
University of California, San Diego
Mandarin Chinese & Culture (NDO), Mandarin Chinese & Culture (NDO) at Peking University
Bilingual International Abitur Diploma, Bilingual International Abitur Diploma at German Swiss International School | 德瑞國際學校
Contributions:1 push, 9 branches, 3 tags in 4 years 7 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.